PPARG and pancreatic neoplasm: The cross-talk of TNF-α, Notch and inhibitor of nuclear factor kappa-B kinase subunit kinase β (Ikk2) (component of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling pathway) leads to a suppression of the nuclear receptor Pparg, in an animal model of pancreatic cancer.